A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy
Clinical trial NCT00236730 · COMPLETED
Trial details
- NCT number
- NCT00236730
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1988-06-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.